EbookBell.com

Most ebook files are in PDF format, so you can easily read them using various software such as Foxit Reader or directly on the Google Chrome browser.
Some ebook files are released by publishers in other formats such as .awz, .mobi, .epub, .fb2, etc. You may need to install specific software to read these formats on mobile/PC, such as Calibre.

Please read the tutorial at this link: https://ebookbell.com/faq

We offer FREE conversion to the popular formats you request; however, this may take some time. Therefore, right after payment, please email us, and we will try to provide the service as quickly as possible.

For some exceptional file formats or broken links (if any), please refrain from opening any disputes. Instead, email us first, and we will try to assist within a maximum of 6 hours.

EbookBell Team

Advances In Clinical Trial Biostatistics Nancy L Geller

Name: Advances In Clinical Trial Biostatistics Nancy L Geller
SKU: BELL-4096688
Price: 31.00 USD
Availability: InStock
Rating: 4.1 (50 reviews)

SKU: BELL-4096688

$ 31.00 ~~$ 45.00~~ (-31%)

4.1

50 reviews

Advances In Clinical Trial Biostatistics Nancy L Geller instant download after payment.

Publisher: Marcel Dekker

File Extension: PDF

File size: 2.15 MB

Pages: 278

Author: Nancy L Geller

ISBN: 9780203912881, 9780824757076, 0203912888, 0824757076

Language: English

Year: 2004

Product desciption

Advances In Clinical Trial Biostatistics Nancy L Geller by Nancy L Geller 9780203912881, 9780824757076, 0203912888, 0824757076 instant download after payment.

From aspects of early trials to complex modeling problems, Advances in Clinical Trial Biostatistics summarizes current methodologies used in the design and analysis of clinical trials. Its chapters, contributed by internationally renowned methodologists experienced in clinical trials, address topics that include Bayesian methods for phase I clinical trials, adaptive two-stage clinical trials, and the design and analysis of cluster randomization trials, trials with multiple endpoints, and therapeutic equivalence trials. Other discussions explore Bayesian reporting, methods incorporating compliance in treatment evaluation, and statistical issues emerging from clinical trials in HIV infection.